Archived News / January 2012

January 31, 2012

Reoperation common after breast-conserving surgery

REUTERS HEALTH

January 30, 2012

Romidepsin effective for refractory peripheral T-cell lymphoma

REUTERS HEALTH

January 30, 2012

Pricey surgery robots lack clear benefits: study

REUTERS HEALTH

January 30, 2012

Hyperbaric O2 helps most chronic radiation injuries: study

REUTERS HEALTH

January 30, 2012

Erivedge (vismodegib) approved for advanced basal cell carcinoma

REUTERS HEALTH

January 30, 2012

Saridegib fails in phase II pancreas cancer trial

REUTERS HEALTH

January 30, 2012

U.S. FDA approves Inlyta (axitinib) for refractory kidney cancer

REUTERS HEALTH

January 30, 2012

Some benefit seen with anastrozole after tamoxifen for early breast cancer

REUTERS HEALTH

January 26, 2012

Gemcitabine plus uracil-tegafur helpful in advanced NSCLC

REUTERS HEALTH

January 26, 2012

Men's hopes for robot prostate surgery unrealistic

REUTERS HEALTH

January 19, 2012

U.S. indoor tanning tax having mixed effects

REUTERS HEALTH

January 18, 2012

FDA approves BTG's drug for cancer toxicity

REUTERS HEALTH

January 9, 2012

Robot prostatectomy no less likely to leave patients disappointed

REUTERS HEALTH

January 6, 2012

PSA screening doesn't prevent cancer deaths: study

REUTERS HEALTH

January 5, 2012

Cancer rates in U.S. keep falling: report

REUTERS HEALTH

January 4, 2012

Hodgkin's lymphoma therapy may bring on early ovarian failure

REUTERS HEALTH

NEWS PROVIDED BY

CURE Media Group About Us | Contact Us | CMG Corporate | Cancer Continuum | Press | FAQs | Write for CURE

Advertise Media Kit | Reprints

Manage Subscription Services | Newsletters | Join the CURE Survey Panel | My Account

Legal Licensing | Terms of Use | Privacy Policy

© 2012 CURE Media Group. All rights reserved. Sitemap

CURE does not provide medical, diagnostic, or treatment advice.